Uncoupling glucosuria from infection: SGLT2 inhibition modulates kidney immune response during pyelonephritis

Laura Schwartz1, John David Spencer1

  • 1Kidney and Urinary Tract Center, Nationwide Children's Hospital, Columbus, Ohio, USA; The Ohio State University College of Medicine, Department of Pediatrics, Columbus, Ohio, USA.

Kidney International
|April 22, 2026
PubMed

Insights

Sodium-glucose cotransporter 2 inhibitors like empagliflozin may not increase severe urinary tract infection risk. Research suggests empagliflozin preserves kidney antibacterial defenses, offering a potential explanation for this clinical observation.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Pharmacology

Background:

  • Sodium-glucose cotransporter 2 (SGLT2) inhibitors increase urinary glucose, theoretically raising urinary tract infection (UTI) risk.
  • Clinical trials show SGLT2 inhibitors do not increase severe UTI rates, creating a therapeutic paradox.

Purpose of the Study:

  • To investigate the mechanistic basis for the observed lack of increased severe UTI risk with SGLT2 inhibition.
  • To explore the effects of empagliflozin on kidney antibacterial defenses and inflammatory responses.

Main Methods:

  • Analysis of human cohort data.
  • Experimental pyelonephritis model in mice.
  • Assessment of C1q expression, inflammatory signaling, and antibacterial defenses.

Main Results:

  • Empagliflozin treatment was associated with reduced C1q expression in the kidney.
  • SGLT2 inhibition preserved key antibacterial defense mechanisms.
  • Altered inflammatory signaling pathways were observed in response to empagliflozin.

Conclusions:

  • SGLT2 inhibition with empagliflozin may modulate kidney antibacterial defenses.
  • These mechanisms could explain the absence of increased severe UTI risk despite increased urinary glucose.
  • Empagliflozin may offer a protective effect on kidney infection defense pathways.

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
15.1K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
817
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
1.5K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.1K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.2K
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
1.4K